CompletedNot applicableNCT02876146

Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole

Studying Alveolar echinococcosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Centre Hospitalier Universitaire de Besancon
Principal Investigator: Frédéric GRENOUILLET, PharmD, PhD
University Hospital Besançon
Intervention: Benzimidazole(drug)
Enrollment: 50 enrolled
Eligibility: 18 years · All sexes
Timeline: 2012 – 2021

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02876146 on ClinicalTrials.gov

Other trials for Alveolar echinococcosis

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT05824442
Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis
Centre Hospitalier Universitaire de Besancon

See all trials for Alveolar echinococcosis →

← Back to all trials